Sofregen Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Private

  • Employees
  • 13

Employees

  • Latest Deal Type
  • Series B

  • Latest Deal Amount
  • $8.1M

  • Investors
  • 3

Sofregen General Information

Description

Manufacturer of a biomedical silk protein intended to facilitate soft tissue regeneration. The company's protein offers plastic surgeons natural biomaterials to enhance their surgical artistry and achieve more durable results, enabling physicians to address soft tissue defects, giving patients a fresh start, restoring confidence, and improving their quality of life.

Contact Information

Website
www.sofregen.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 175 Crossing Boulevard
  • Suite 510
  • Framingham, MA 01702
  • United States
+1 (617)
Primary Industry
Other Devices and Supplies
Other Industries
Biotechnology
Vertical(s)
Life Sciences
Corporate Office
  • 175 Crossing Boulevard
  • Suite 510
  • Framingham, MA 01702
  • United States
+1 (617)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Sofregen Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC (Series B) 03-Sep-2019 $8.1M Completed Generating Revenue
4. Early Stage VC (Series A) 27-Sep-2017 Completed Generating Revenue
3. Debt - General Completed Startup
2. Seed Round 01-Jan-2014 $1.6M $1.6M Completed Startup
1. University Spin-Out 01-Jan-2014 Completed Startup
To view Sofregen’s complete valuation and funding history, request access »

Sofregen Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series B
Series A
Seed 1,674,327 $0.000100 6% $0.79 $0.79 1x $0.79 8.51%
To view Sofregen’s complete cap table history, request access »

Sofregen Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Manufacturer of a biomedical silk protein intended to facilitate soft tissue regeneration. The company's protein offers
Other Devices and Supplies
Framingham, MA
13 As of 2024

Hopkinton, MA
 

Pune, India
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Sofregen Competitors (14)

One of Sofregen’s 14 competitors is Isto Biologics, a Private Equity-Backed company based in Hopkinton, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Isto Biologics Private Equity-Backed Hopkinton, MA
Serigen Venture Capital-Backed Pune, India
NOVADIP Venture Capital-Backed Mont-Saint-Guibert, Belgium
TELA Bio Formerly VC-backed Malvern, PA
BioTissue (Biotechnology) Venture Capital-Backed Miami, FL
You’re viewing 5 of 14 competitors. Get the full list »

Sofregen Patents

  • 22

    Total Documents Applications and Grants

  • Total Patents Families

  • 12

    Granted

  • 1

    Pending

  • Expiring in next 12 mo

Sofregen Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4045124-A1 Delivery devices for delivering and methods of delivering compositions Inactive 15-Oct-2019
EP-4045124-A4 Delivery devices for delivering and methods of delivering compositions Inactive 15-Oct-2019
US-11738174-B2 Delivery devices for delivering and methods of delivering compositions Active 15-Oct-2019
US-20210106788-A1 Delivery devices for delivering and methods of delivering compositions Active 15-Oct-2019
US-20240024630-A1 Delivery devices for delivering and methods of delivering compositions Inactive 15-Oct-2019 A61M25/0136
To view Sofregen’s complete patent history, request access »

Sofregen Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Sofregen Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
Anzu Partners Venture Capital Minority
Polaris Partners Venture Capital Minority
Tufts University University
To view Sofregen’s complete investors history, request access »

Sofregen Investments (1)

Sofregen’s most recent deal was a Corporate Asset Purchase with Seri (Surgical Scaffold product line). The deal was made on 11-Nov-2016.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Seri (Surgical Scaffold product line) 11-Nov-2016 Corporate Asset Purchase Medical Supplies
To view Sofregen’s complete investments history, request access »

Ready to get started?

Request a free trial

Sofregen FAQs

  • When was Sofregen founded?

    Sofregen was founded in 2014.

  • Where is Sofregen headquartered?

    Sofregen is headquartered in Framingham, MA.

  • What is the size of Sofregen?

    Sofregen has 13 total employees.

  • What industry is Sofregen in?

    Sofregen’s primary industry is Other Devices and Supplies.

  • Is Sofregen a private or public company?

    Sofregen is a Private company.

  • What is the current valuation of Sofregen?

    The current valuation of Sofregen is .

  • What is Sofregen’s current revenue?

    The current revenue for Sofregen is .

  • How much funding has Sofregen raised over time?

    Sofregen has raised $22.9M.

  • Who are Sofregen’s investors?

    Anzu Partners, Polaris Partners, and Tufts University have invested in Sofregen.

  • Who are Sofregen’s competitors?

    Isto Biologics, Serigen, NOVADIP, TELA Bio, and BioTissue (Biotechnology) are some of the 14 competitors of Sofregen.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process